Full access
Clinical & Research News
Published Online: 4 May 2001

Psychoactive Drugs on Registry to Date

Publication: Psychiatric News
Volume 36, Number 9
https://doi.org/10.1176/pn.36.9.0041a
Track CitationsAdd to favorites
Fourteen psychoactive medications are listed on the registry of drugs that are either known to cause, or suspected of increasing a patient’s risk of, a potentially fatal cardiac arrhythmia called torsades de pointes.
The list of drugs for which cases of suspected drug-induced torsades de pointes are documented in the literature includes the antidepressants amitriptyline, desipramine, doxepin, and imipramine. Cases are also documented for the antipsychotics chlorpromazine and pimozide, both of which pose a higher risk of inducing arrhythmias in women than men.
Those drugs on the registry’s list shown to prolong the QT interval, and therefore increase theoretical risk for developing torsades de pointes, include the antidepressants fluoxetine and sertraline, although the association is not clear. A clearer link exists for the antidepressant venlafaxine and the antipsychotics haloperidol, mesoridazine, quetiapine, risperidone, and thioridazine.
The link between these drugs and the potential to cause harmful arrhythmias is thought to be due to the medications’ ability to alter electrolyte balances within the heart muscle cells. The result is a delay in the heart’s “resetting” of its electrolytes in anticipation of the next heartbeat. If the next heartbeat occurs without the electrolytes fully reset, the heartbeat may not conduct normally.
Psychiatric patients at highest risk of developing a drug-induced prolongation of the QT interval commonly have comorbid cardiovascular disease. In addition, risk increases with kidney or liver disorders and with age. Women are also at somewhat higher risk, simply because they generally have a longer QT interval than men. The most significant risk factor is the presence of multiple medications.

Information & Authors

Information

Published In

Go to Psychiatric News
Psychiatric News
Volume 36 • Number 9 • May 4, 2001
Pages: 41

History

Published online: 4 May 2001
Published in print: May 4, 2001

Authors

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard
Tips for downloading citations

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share

×

As described within the American Psychiatric Association (APA)'s Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences. Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.